CHICAGO, Feb. 12, 2020 /PRNewswire/ -- Chicago-based intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP (MBHB) is pleased to announce the launch of its Cannabis Practice Group. Led by Nicole Grimm and George "Trey" Lyons III, MBHB partners and chairs of the firm's Cannabis Practice Group, the practice will offer full-spectrum intellectual property support and counseling for cannabis clients ranging from startups to established companies.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Berghoff LLP
USPTO Presentation on Evaluating Computer-Implemented Functional Claiming under 35 U.S.C. § 112 | JD Supra
On June 11, 2019, the U.S. Patent and Trademark Office held a public presentation -- a patent quality chat -- regarding the interpretation of computer-implemented claims using functional language under 35 U.S.C. § 112. Mostly, this presentation was an overview of the USPTO's January 7, 2019 Federal Register notice on the same topic.
Congress Proposes Draft Bill to Change 35 U.S.C. § 101 | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (Fed. Cir. 2018) | JD Supra
Ever since the Supreme Court loosened the reins on declaratory judgment actions in patent cases twelve years ago, in MedImmune v. Genentech, courts have decided cases fleshing out the metes and bounds of the factual predicates thereof.
House Bill Would Establish National Security Commission On Artificial Intelligence
Energy industry news, analysis, and commentary By Aaron Gin | McDonnell Boehnen Hulbert & Berghoff LLP on April 10, 2018 at 3:00 PM Sign up and get Breaking Energy news in your inbox. × Sign up and get Breaking Energy news in your inbox.
Patent Exhaustion: Supreme Court Expands Patent-Limiting Doctrine
The U.S. Supreme Court at the end of the past term handed down a decision, Impression Products, Inc. v. Lexmark International, Inc., that greatly expanded the doctrine of patent exhaustion.[1] This equitable doctrine prevents a patent holder from restricting further sales or use of a patented invention once the patentee has received the benefits of her patent from a first sale. In doing so, the Court upset the settled expectations of many patent holders and their licensees.
After The Failed Trans-Pacific Partnership What Comes Next
By Joshua Rich, partner, McDonnell Boehnen Hulbert & Berghoff LLP The Obama Administration, seeking to expand international trade, negotiated the Trans-Pacific Partnership (TPP) with 11 other Pacific Rim countries. After President Trump assumed office in January, he immediately withdrew the U.S. from the multilateral agreement. The other TPP countries — now known as the TPP 11 — and other Asian countries have since been seeking a replacement low-tariff trade market.
USPTO Proposes Revisions to Materiality Standard
On October 28, the U.S. Patent and Trademark Office published a notice of proposed rulemaking in the Federal Register (81 Fed. Reg. 9451), proposing revisions to the materiality standard for the duty to disclose information in patent applications and reexamination proceedings. The Office previously issued a notice of proposed rulemaking regarding the same rules in July 2011 following the Federal Circuit's decision in Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir.
USPTO Seeks Comments on New Sequence Standard
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
In re NuVasive, Inc. (Fed. Cir. 2016)
The Federal Circuit remanded a final written decision of the Patent Trial and Appeal Board ("PTAB" or "Board") because the Board invalidated certain claims in a patent without providing adequate notice or opportunity to the patentee to respond to an assertion about a prior art reference. Interestingly, in the In re NuVasive, Inc.
Early Reaction to Presidential Election Results
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Location-Based Online Gaming Patents Found to be Directed to Patentable Subject Matter
Plaintiff CG Technology Development, LLC sued Defendants Bwin.Party Digital Entertainment, PLC in the U.S. District Court for the District of Nevada for infringement of various patents via operation of various online casino games. Bwin filed a motion to dismiss infringement as to U.S. Patents 8,771,058; 8,814,664; 9,355,518; and 9,306,952 based on unpatentability under 35 U.S.C. § 101.
USPTO to Hold Roundtables on Subject Matter Eligibility
In a notice published in the Federal Register (81 Fed. Reg. 71485) last month, the U.S. Patent and Trademark Office announced that it will be holding two roundtables in order to obtain public input on patent subject matter eligibility in view of recent decisions by the Supreme Court and Federal Circuit.
USPTO Issues Memorandum on Recent Subject Matter Eligibility Decisions
On November 2nd, the U.S. Patent and Trademark Office published an update to its guidance regarding the examination of claims with respect to the patent-eligibility requirements of 35 U.S.C. § 101 (see Memorandum entitled "Recent Subject Matter Eligibility Decisions"). Notably, this update addresses the recent McRO v. Bandai Namco Games America and BASCOM Global Internet Services v. AT&T Mobility Federal Circuit cases, both of which found challenged claims to be eligible.
In re Efthymiopoulos (Fed. Cir. 2016)
Last month, in In re Efthymiopoulos, the Federal Circuit affirmed the determination by the U.S. Patent and Trademark Office Patent Trial and Appeal Board affirming the Examiner's rejection of all pending claims of Appellant Constantin Efthymiopoulos's U.S. Patent Application No. 08/737,141 as being obvious. The '141 application relates to methods of treating or preventing influenza by administering the drug zanamivir by oral inhalation. Claim 14 is representative: 14.
Guest Post -- The Emergent Microbiome: A Revolution for the Life Sciences -- Part VIII, The Microbiome and Immunotherapy I
Cancer immunotherapy or immuno-oncology (I-O) has gone mainstream. You may have heard about these topics in the media. Along with having surgery and radiation therapy, Former President Jimmy Carter was treated with the monoclonal antibody pembrolizumab (Keytruda®) that stimulated his immune system to fend or fight off melanoma that had metastasized to his brain. His remarkable response has highlighted the power of immunotherapy.
Synopsis, Inc. v. Mentor Graphics Corp. (Fed. Cir. 2016)
Synopsys brought a patent infringement action against Mentor Graphics in the Northern District of California, alleging infringement of various claims of U.S. Patent Nos. 5,530,841, 5,680,318, 5,748,488, and 6,836,420.
PTAB Life Sciences Report - October 2016
About the PTAB Life Sciences Report: Each month we will report on recent developments at the PTAB involving life sciences patents.
Massachusetts Institute of Technology v. Shire Pharmaceuticals, Inc. (Fed. Cir. 2016)
The Federal Circuit recently affirmed a district court's claim construction and determination that claim terms were not indefinite in Massachusetts Institute of Technology v. Shire Pharmaceuticals, Inc. The case involved U.S. Patent Nos. 5,770,193 and 5,759,830, directed to three-dimensional scaffolds for growing cells in vitro for in vivo organ culture.
USPTO Seeks Comments and Will Hold Roundtables on Examination Time
In a Federal Register notice (81 Fed. Reg. 73383) published last week, the U.S. Patent and Trademark Office issued a request for public feedback regarding the Office's reevaluation of its examination time goals. The Office also announced that it would be holding five roundtables in Alexandria, VA; Detroit, MI; Denver, CO; Dallas, TX; and San Jose, CA as part of its Examination Time Analysis (ETA).
Intellectual Ventures I LLC v. Symantec Corp. -- Judge Mayer on the First Amendment
Decided September 30th, this Federal Circuit case is already making waves. The majority opinion seems to be at tension with the Court's outcome in BASCOM Glob. Internet Servs., Inc. v. AT&T Mobility LLC, but the real attention-grabber is Judge Mayer's concurrence. Therein, he argued that claims such as those under review were at odds with the First Amendment, and then reiterated his position that software is not patent eligible.
Medtronic, Inc. v. Robert Bosch Healthcare Systems, Inc. (Fed. Cir. 2016) - Federal Circuit Denies Petition for Rehearing in Medtronic v. Robert Bosch Healthcare Systems | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra
One of the aspects of inter partes review that differed from other post-grant review proceedings before the Board of Patent Appeals and Interferences (succeeded by the Patent Trial and Appeal Board) is a requirement for transparency with regard to the "real party in interest": unlike in ex parte reexamination, for example, the inter partes review provisions of the Leahy-Smith America Invents Act require that a petition for inter partes review identify the real party in interest.
Perdiemco, LLC. v. Industrack LLC (E.D. Tex. 2016)
In the U.S. District Court for the Eastern District of Texas, in a case captioned Perdiemco, LLC. v. Industrack LLC, the Court found some patents having method claims directed to "conveying user location" to be patent-eligible under 35 U.S.C. § 101. Much of the reasoning was based on the recent Federal Circuit decision McRO, Inc. v. Bandai Namco Games America Inc., and even though the claims are generally broad and only include basic/generic computer components, the claims survived a § 101 challenge.
Purported Public Interest Group Challenges Drug Patent in Qui Tam Action
The intersection of patent law, drug regulations, creative lawyering, and commerce (if not outright greed) has once again arisen in a qui tam suit brought under 31 U.S.C. §§ 3729–3733 (alleging fraud against the U.S. Government) by Lower Drug Prices for Consumers (LDPFC), reportedly an arm of Foxhill Capital, in USA ex rel. Lower Drug Prices for Consumers (LDPFC) v. Allergan and Forest Labs, Case No. 16-cv-09 (E.D. Texas 2016).
PTAB Update -- Patent Office Proposes Rule Amendment to Recognize Patent Agent-Client Privilege
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Guest Post -- Recent Software Case Gives Important Lessons for Biotech
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
September Was a Good Month for Patent Eligibility in the District Courts
Anecdotally, there seems to be a loosening up regarding the application of § 101 by the District Courts. The 2014 Supreme Court decision in Alice Corp. v. CLS Bank Int'l has been referred to as sounding a death knell for software and business method patents, and (less hyperbolically) as a sea-change in the law of patent-eligibility. Indeed, for the first two years after Alice came down, decisions rendering challenged patents ineligible under § 101 held around 65-70% in the District Courts.
Second Quarter Venture Funding Increases 20% from First Quarter
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
RWS Inovia Releases 2016 Report on Global Patent Trends
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
FairWarning IP, LLC v. Iatric Systems, Inc. (Fed. Cir. 2016) - Rule-Based Data Processing Patent Held to Be Directed to Patent-Ineligible Subject Matter | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra
On October 11, 2016, the Federal Circuit issued a precedential opinion in FairWarning IP, LLC v. Iatric Systems, Inc. affirming dismissal of a patent infringement suit brought by FairWarning holding that the asserted patent, U.S. Patent No. 8,578,500, claims patent-ineligible subject matter under 35 U.S.C. § 101. The Federal Circuit essentially found that the claims were directed to a combination of previously identified abstract-idea categories, and thus, they were found invalid.
USPTO Implements Enhanced Patent Assignment Search
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Guest Post -- The Emergent Microbiome: A Revolution for the Life Sciences -- Part VII, The Microbiology of the Built Environment
Many research efforts into the microbiome have focused primarily on the human microbiome, i.e., microorganisms within and on the body, and how changes in these microbial communities correlate with changes in health and disease. Less attention, however, has been paid to the microbial communities external to humans and how changes in these communities can affect health.
Intellectual Ventures I LLC v. Symantec Corp. (Fed. Cir. 2016) - Just When You Thought the Federal Circuit Was Softening Restrictions on Software Patents, the Tide Turns Again | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra
Intellectual Ventures I LLC ("IV") sued Symantec Corp. and Trend Micro (defendants) for infringement of various claims of three U.S. Patents (Nos. 6,460,050; 6,073,142; and 5,987,610). The District Court held the asserted claims of the '050 patent and the '142 patent to be ineligible under § 101, and the asserted claim of the '610 patent to be eligible.
Supreme Court Again Refuses to Clarify Scope of Hatch-Waxman Safe Harbor
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
USPTO Announces 2016 Patents for Humanity Winners
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Plaid Technologies Inc. v. Yodlee, Inc. (PTAB 2016) - CBM Petition Denied for Patent Lacking Financial Product or Financial Activity in the Claims
In a recent decision, the Patent Trial and Appeal Board (PTAB) denied the institution of a covered business method (CBM) patent review on an Internet Portal System patent because the claims lacked any recitation of a financial product or financial activity.
BMC Software, Inc. v. zIT Consulting GmbH (PTAB 2016) - CBM Patent Review Denied for Claims Lacking Financial Subject Matter
The PTAB denied institution of a covered business method (CBM) patent review in a case between BMC Software Inc. (Petitioner) v. zIT Consulting GmbH (Patent Owner). Petitioner, BMC Software, Inc., filed a Petition to institute a CBM patent review of claims 1–29 of U.S. Patent No. 8,904,405, owned by zIT Consulting GmbH.
PTAB Life Sciences Report - September 2016 #2
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Tridim Innovations LLC v. Amazon.com, Inc. (N.D. Cal. 2016)
Tridim Innovations LLC sued Amazon.com, Inc. for patent infringement of U.S. Patent Nos. 5,838,326 and 5,847,709 in the U.S. District Court for the Northern District of California. Amazon moved to dismiss TriDim's claims for invalidity under 35 U.S.C. § 101. The District Court granted the motion to dismiss finding that the patents are directed to ineligible subject matter under section 101.
FDA Approves Amjevita -- Amgen's HUMIRA® Biosimilar
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Yeda Research and Development Co. v. Abbott GmbH & Co. (Fed. Cir. 2016)
Before the Supreme Court's recent forays into the topic of subject matter eligibility in patent law, the most contentious line of cases (from the Federal Circuit) concerned the written description requirement of Section 112. Indeed, some (like former Chief Judge Rader) believed that the statute does not contain a separate written description requirement, an opinion firmly shut down by the Court's en banc decision in Ariad v.
Iron Gate Security, Inc. v. Lowe's Companies, Inc. (S.D.N.Y. 2016)
Iron Gate, holder of U.S. Patent No. 7,203,693, sued Lowe's in the Southern District of New York, alleging infringement. Lowe's moved to dismiss under Rule 12(b)(6), contending that the claims of the patent failed to meet the patent-eligibility requirements of 35 U.S.C. § 101.
LifeNet Health v. LifeCell Corp. (Fed. Cir. 2016)
The complexities that can be attendant on defending against an infringement allegation, and the possibility that a straightforward path to non-infringement can be complicated by claim construction even for terms construed using their plain meaning, are illustrated in the Federal Circuit's opinion affirming a jury verdict of infringement in LifeNet Health v. LifeCell Corp.
Zak v. Facebook, Inc. (E.D. Mich. 2016) - Software Patent Found to Be Directed to Abstract Idea, But Survives § 101 Challenge with Inventive Concept
Bruce Zak, an individual, sued Facebook, Inc. for patent infringement in the U.S. District Court for the Eastern District of Michigan on two of his software patents -- United States Patent Nos. 8,713,134 and 9,141,720. Facebook moved for summary judgment arguing that the subject matter of the two patents is not eligible for patent protection under § 101.
FDA Approves Release of Genetically Engineered Mosquitoes
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
USPTO Announces Changes to EFS-Web Payments for Deposit Accounts and EFTs
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
MBHB Snippets: A review of developments in Intellectual Property Law - Volume 14, Issue 3
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
USPTO News Briefs - September 2016
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
McRO, Inc. v. Bandai Namco Games America Inc. (Fed. Cir. 2016)
Patentee McRO sued a number of video game developers and publishers in the Central District of California and the District of Delaware for alleged infringement of U.S. Patent Nos. 6,307,576 and 6,611,278. Several of the Delaware suits were transferred to the Central District of California, and the defendants filed a Rule 12(c) motion therein to invalidate the claims as allegedly being directed to ineligible subject matter under 35 U.S.C. § 101.
The Impact of 3D printing on Intellectual Property Rights
The term 3D printing encompasses a number of different additive manufacturing methods that enable the production of physical objects without the need for any specific tooling.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Berghoff
Contact Berghoff, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack